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Abstract. We report a case of disseminated tuberculosis caused by a vaccine strain of tuberculosis in a five-month-old 
infant that presented as severe systemic infection. Unfortunately, the infant died five days after admission. After the patient’s 
death, the diagnosis was made based on pathohistological changes and a pharyngeal aspirate culture. 
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Introduction 

 
Tuberculosis, an infectious disease caused by 
Mycobacterium tuberculosis, remains a leading public 
health problem worldwide [1]. In young children, 
tuberculosis is often disseminated due to the early, 
haematogenous spread of the bacterium after the 
primary pulmonary infection [2]. The first molecular 
evidence that a predisposition to tuberculosis might 
reflect inborn errors in immunity was provided by the 
occurrence of overwhelming tuberculosis in children 
with rare, severe primary immunodeficiencies (PIDs) [3, 
4]. Disseminated disease in children with PIDs is often 
caused by widespread, weakly virulent mycobacteria, 
such as bacillus Calmette-Guerin (BCG) vaccines and 
environmental mycobacteria. There are some reports in 
the literature on patients with immunodeficiencies who 
developed tuberculosis [3, 4]. Complications of bacillus 
Calmette-Guerin (BCG) vaccination are uncommon. 
Fewer than one in 1000 vaccinated people develop 
significant local reactions, and serious disseminated 
disease develops in fewer than one in one million [5, 6].  
Herein, we report a case of disseminated BCG 
tuberculosis caused by the bacillus Calmette-Guerin 
(BCG) vaccine in an infant who died of multiple organ 
failure. 
Case Report  
The patient was a boy that was born at term to 
nonconsanguineous parents of Roma origin. His birth 
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size was normal, 50 cm and 3100 g, and he had no overt 
developmental defects. He was vaccinated with the 
BCG vaccine on the third day of life. Both parents, who 
had been previously vaccinated with BCG, were 
healthy, and he was their only child. The family’s living 
conditions were good. The infant was healthy until 3.5 
months of age, when fever and cough developed. He 
was hospitalised twice in a local hospital and received 
antibiotics due to urinary and respiratory infections. The 
treatment did not result in significant improvement, and 
the infections caused a failure to thrive.  
When five months old, the infant was admitted to 
the intensive care unit of the Pediatric Clinic in Nis, 
Serbia, with fever, respiratory distress and lethargy. At 
the time of admission, he was severely ill and had a 
temperature of 39°C, a respiratory rate of 68 per minute 
and a heart of was 160 beats per minute. The patient 
was pale, underdeveloped and undernourished, and 
weighed 4400 g, which was below the 3
rd
 percentile. 
The examination showed that he exhibited, nasal 
flaring, intercostal retractions, wheezing, decreased 
breath sounds over both lungs and granulomatous 
dermatitis. He was hypotonic, with modest spontaneous 
movements. The abdominal examination showed 
distension and hepatosplenomegaly. 
Laboratory tests performed on admission revealed 
hypochromic anaemia and leukocytosis (table 1). 
Inflammatory parameters were high. The blood urea 
nitrogen, creatinine, and electrolyte levels were within 
normal limits. Arterial blood gas analysis showed mild 
respiratory alkalosis. Standard liver panel tests revealed 
the following results: ALT 29 IU/l (range 040); AST 
69 U/L (range 040); alkaline phosphatase 346 U/L; 
total protein 49.4 gr/L; albumin 28 gr/L; total bilirubin 
13.19 μmol/l; LDH 883 μ/l, uric acid 118 μmol/l; 
prothrombin time 11.5 seconds and partial prothrombin 
time 31.9 seconds. Immunological examination revealed 
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a decreased level of IgG 0.09 g/l and an IgM level of 
0.20 g/l. Immunoglobulin A1 (IgA1) and IgE were 
within normal limits. The spontaneous and stimulated 
levels of reduction of nitroblue tetrazolium by 
neutrophilic polymorphonuclear leukocytes (NBT) were 
6% and 68%, respectively. The results of the urine 
analysis was normal. The cerebrospinal fluid (CSF) 
obtained from the lumbar puncture was haemorrhagic. 
The blood culture was negative. A deep pharyngeal 
aspirate revealed Escherichia coli (ESBL+). The direct 
microscopic analysis of three deep pharyngeal aspirates 
for acid-fast bacilli was negative. Lowenstein Jensen 
culture of the deep pharyngeal aspirate identified 
bacillus Calmette-Guerin, but the results were not 
obtained until eight weeks after the patient’s death.  
A chest X-ray showed a slightly enlarged right hilar 
and perihilar and apical infiltrations (Figure 1). 
Abdominal sonography revealed mild hepatomegaly and 
prominent splenomegaly, with diffuse hypoechogenic 
focal changes (<10 mm) (Figure 2). CNS sonography 
revealed mild ventriculomegaly. 
Initial therapy included fluids, oxygen, antibiotics 
(ceftazidime, vancomycin), and supplements, but the 
patent’s symptoms did not resolve. The infant died due 
to multiple organ failure five days after admission. 
Autopsy results showed granulomatous lesions in the 
spleen, liver (Figure 3) and skin. The pathohistological 
examination of the lungs showed changes typical of a 
cytomegalovirus infection.    
Table 1 Laboratory findings 
Variable Reference range At admission 4
th
 day 
Haematology 
Red blood cells (10
6
/µL)  4.70 – 5.80 4.08 4.06 
Haemoglobin (g/dl)  11.0 – 18.0 7.8 ↓ 8.7 
Haematocrit (%)  51.0 – 59.0 28.8 ↓ 30.7 
Platelets (10
3
/µL)  100 – 310 200 251 
White blood cells (10
3
/µL)  9.0 – 19.0 20.3 19.9 
Neutrophils (%)  45.0 – 50.0 70.4 82.2 
Monocytes (%)  3.0 – 5.0 3.0 2.4 
Lymphocytes (%)  34.0 – 40.0 26.6 15.4 
Biochemistry 
Total protein (g/L)  60 – 80 49.4 ↓ 48.7 
Albumin (g/L)  30 – 51 28 ↓ 28.9 
Parameters of inflammation 
C-reactive protein (mg/dl)   0 – 5 166 121 
Fibrinogen (g/L)  2 – 4 6.79 / 
Capillary blood gas analysis on FiO2 40%  
pH   7.35 – 7.45 7.52 7.54 
PkO2 (mmHg)   60 – 80 39↓ 48↓ 
PkCO2 (mmHg)   35 – 45 32 ↓ 33↓ 
Virology, Bacteriology 
Elisa test for TORCH  Negative / 
Deep pharyngeal aspirate 
Bacteriological culture 
 Escherichia coli 
(ESBL+)  
/ 
Blood culture   Negative / 
Aspirate smear microscopy AFB   Negative / 
Mycobacterial culture   Positive: bacillus 
Calmette–Guérin 
/ 
CSF analysis 
Haemorrhagic, Pandy + 
Biochemical analysis: 
CSF glucose/serum glucose 
Cl (mEq/l)  96 – 120 
1,5 
120 
/ 
Cytological examination  Negative / 
Bacteriological culture  Negative / 
Immunological analysis 
IgA   0.058 – 0.858 <0.24 / 
IgM (g/l)  0.264 – 1.46 0.20 ↓ / 
IgG (g/l)  2.68 – 8.98 0.09 ↓ / 
IgE (IU/ml) < 15 <4.2  / 
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Fig. 1 Chest X-ray showed slightly enlarged right hilar 
lymph node and perihilar and apical infiltrations. 
 
 
 
Fig 2 Mild hepatomegaly and prominent splenomegaly, 
with diffuse hipoechogenic focal changes (<10mm). 
 
Fig. 3 There are granulomas (caseous) made of epithelioid 
cells in the liver parenchyma. There is caseous 
necrosis in the center of certain granulomas, and 
Langhan's giant cells (H&E 10) on the periphery. 
Discussion 
Tuberculosis (TB) continues to be one of the most 
devastating and widespread infections in the world. 
Young children are most likely to develop the disease 
after infection and are significantly more likely to 
develop extra-pulmonary and severely disseminated 
disease than adults [5]. 
Severe disseminated disease occurs early after the 
infection, within the first 2 to 6 months, and may 
represent an uncontrolled primary infection in children. 
The clinical manifestations of disseminated disease are 
protean, with involvement of the lungs, spleen, and 
bone marrow. Like adults with miliary TB, children are 
usually smear negative. With progressive pulmonary 
disease, respiratory distress, hypoxia, and pneumothorax/ 
pneumomediastinum may occur. Symptoms of the 
disease in our patients were fever, loss of appetite, 
respiratory distress and lethargy. The initial manifestation 
of disease in our patient involved the lungs, liver, 
spleen, and skin and included the possible early stages 
of meningitis.  
Immunity to tuberculosis involves complex interactions 
between various cell populations to control and contain the 
infection and prevent further reactivation, but this 
response can also contribute to tissue damage. Cell-
mediated immune mechanisms provide protection and 
delayed-type hypersensitivity [7]. The balance of Th1 
and Th2 cytokines appears critical to controlling TB 
infection. Further evidence of the importance of 
interferon-γ can be found in children with hereditary 
IFN-γ receptor 1 deficiency. These children are prone to 
overwhelming infections with environmental mycobacteria 
and to the dissemination of bacilli Calmette-Guerin (BCG) 
after BCG vaccination. Together these data suggest that 
Th1 responses are protective, whereas Th2 responses 
are associated with chronic disease [8, 9]. In our patient, 
we ruled out chronic granulomatous disease using the 
NBT test. The serum levels of IgM and IgG were 
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decreased in comparison to the age-appropriate reference 
values. The initial treatment consisted of antibiotics, 
oxygenotherapy, and symptomatic therapy, that is, 
therapy to treat severe sepsis. Eight weeks after the 
patient’s death, the Lowenstein Jensen culture identified 
bacillus Calmette-Guerin. We were not able to perform 
more detailed immunological tests. Cases of tuberculosis  
in children with malignant diseases [10, 11] and 
immunodeficiencies [12] have been reported in the 
literature, but there are few cases involving deficiencies in 
the receptors for interferon gamma and immunoregulatory 
factor 8 [8, 9, 13]. 
A specific immunodeficiency can be identified in 
only about half of the cases disseminated BCG infection 
[14]. In the other cases, the pathogenesis remains unclear. 
Such idiopathic cases have been reported in 24 countries, 
with a prevalence in France of at least 0.59 case per 1 
million children vaccinated with BCG [15]. The high rates 
of consanguinity (30 per cent) and familial forms (17 per 
cent) and the equal sex distribution support the hypothesis 
of a new type of primary immune disorder with an 
autosomal recessive pattern of inheritance [15]. The 
parents of our patient are nonconsanguineous, and there 
were no similar diseases in other family members.  
Conclusion 
We have presented the case of an infant with disseminated 
mycobacterial disease after BCG vaccination that had a 
fatal outcome. Despite the use of modern diagnostics and 
treatments, such cases are difficult to diagnose and are 
even more difficult to cure. In most countries, the definitive 
diagnosis of macrophage function disorders (which 
involves analysing interleukin 12, interferon gamma, and 
the receptors for these cytokines and immunoregulatory 
factors) is difficult, which contribute to severe infections 
such as disseminated tuberculosis. To decrease the 
morbidity and mortality rates of disseminated tuberculosis 
caused by the BCG vaccine, further research is required 
to identify the basic causes of immune system disorders 
and to develop new therapies. 
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